The role of Self-Nanoemulsifying drug delivery systems of CDODA-Me in sensitizing Erlotinib-Resistant non–small cell lung cancer
We have investigated the effects of combination treatment involving ERL (erlotinib) with a
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
[PDF][PDF] The role of Self Nano Emulsifying drug delivery systems of CDODA-Me in sensitizing Erlotinib resistant Nonsmall cell lung cancer
E Nottingham - Journal of pharmaceutical sciences, 2020 - par.nsf.gov
abstract We have investigated the effects of combination treatment involving ERL (erlotinib)
with a glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing …
with a glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing …
The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non-Small Cell Lung Cancer
E Nottingham, V Sekar, A Mondal… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
We have investigated the effects of combination treatment involving ERL (erlotinib) with a
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non–Small Cell Lung Cancer
E Nottingham, V Sekar, A Mondal, S Safe… - Journal of …, 2020 - jpharmsci.org
We have investigated the effects of combination treatment involving ERL (erlotinib) with a
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non-Small Cell Lung Cancer.
E Nottingham, V Sekar, A Mondal, S Safe… - Journal of …, 2020 - europepmc.org
We have investigated the effects of combination treatment involving ERL (erlotinib) with a
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
[HTML][HTML] The Role of Self-Nanoemulsifying Drug Delivery Systems of CDODA-Me in Sensitizing Erlotinib-Resistant Non–Small Cell Lung Cancer
E Nottingham, V Sekar, A Mondal, S Safe… - Journal of …, 2020 - ncbi.nlm.nih.gov
We have investigated the effects of combination treatment involving ERL (erlotinib) with a
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …
glycyrrhetinic acid analog, CDODA-Me in overcoming ERL resistance, providing efforts to …